USE OF CORTICOSTEROIDS AND ADJUVANTS IN THE TREATMENT OF BACTERIAL MENINGITIS

Introduction: Bacterial meningitis remains a critical cause of morbidity and mortality worldwide, particularly among neonates, children, and immunocompromised individuals. While antibiotic therapy remains the cornerstone of treatment, inflammatory responses triggered by bacterial lysis contribute significantly to neurological complications. In this context, corticosteroids and other adjunctive therapies have been investigated to modulate immune-mediated damage. Objective: This review aims to explore and synthesize the current evidence on the efficacy and limitations of corticosteroids and other adjuvant agents in bacterial meningitis treatment. Secondary objectives include assessing variations in response based on age, causative organisms, and timing of administration. Methods: A narrative review was conducted using data from PubMed, Scopus, Web of Science, Cochrane Library, and Google Scholar. Studies from the last five years were selected based on relevance to corticosteroid or adjunctive use in the management of acute bacterial meningitis. Clinical trials, meta-analyses, guidelines, and large observational cohorts were prioritized. Results and Discussion: Dexamethasone has shown benefit in reducing hearing loss in cases of pneumococcal meningitis, particularly in high-income countries when administered before or with the first dose of antibiotics. However, its utility in meningococcal or Haemophilus influenzae infections remains inconsistent. New adjuvants under investigation include glycerol, paracetamol, and immunomodulatory agents targeting cytokine cascades, although their clinical application is not yet standardized. Conclusion: Corticosteroids represent a valuable adjunct in the management of bacterial meningitis under specific conditions. Their use should be tailored according to etiology, age group, and regional epidemiological patterns. Continued research into novel adjuvants is essential to improve outcomes and reduce long-term sequelae.

Authors

Publication Details

Journal
Asclepius International Journal of Scientific Health Science
Published
2025-08-04
DOI
https://doi.org/10.70779/aijshs.v4i8.248
Primary Topic
Bacterial Infections and Vaccines
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

USE OF CORTICOSTEROIDS AND ADJUVANTS IN THE TREATMENT OF BACTERIAL MENINGITIS

H. Silva, Elisabeth Dotti Consolo, Ana Pires, Vivian Ivone Pereira Negrão
Asclepius International Journal of Scientific Health Science
Bacterial Infections and Vaccines
article

USE OF CORTICOSTEROIDS AND ADJUVANTS IN THE TREATMENT OF BACTERIAL MENINGITIS

H. Silva, Elisabeth Dotti Consolo, Ana Pires, Vivian Ivone Pereira Negrão
article en

Abstract

Introduction: Bacterial meningitis remains a critical cause of morbidity and mortality worldwide, particularly among neonates, children, and immunocompromised individuals. While antibiotic therapy remains the cornerstone of treatment, inflammatory responses triggered by bacterial lysis contribute significantly to neurological complications. In this context, corticosteroids and other adjunctive therapies have been investigated to modulate immune-mediated damage. Objective: This review aims to explore and synthesize the current evidence on the efficacy and limitations of corticosteroids and other adjuvant agents in bacterial meningitis treatment. Secondary objectives include assessing variations in response based on age, causative organisms, and timing of administration. Methods: A narrative review was conducted using data from PubMed, Scopus, Web of Science, Cochrane Library, and Google Scholar. Studies from the last five years were selected based on relevance to corticosteroid or adjunctive use in the management of acute bacterial meningitis. Clinical trials, meta-analyses, guidelines, and large observational cohorts were prioritized. Results and Discussion: Dexamethasone has shown benefit in reducing hearing loss in cases of pneumococcal meningitis, particularly in high-income countries when administered before or with the first dose of antibiotics. However, its utility in meningococcal or Haemophilus influenzae infections remains inconsistent. New adjuvants under investigation include glycerol, paracetamol, and immunomodulatory agents targeting cytokine cascades, although their clinical application is not yet standardized. Conclusion: Corticosteroids represent a valuable adjunct in the management of bacterial meningitis under specific conditions. Their use should be tailored according to etiology, age group, and regional epidemiological patterns. Continued research into novel adjuvants is essential to improve outcomes and reduce long-term sequelae.

Asclepius International Journal of Scientific Health ScienceVol. 4(8)
Openalex Percentile: Top 82%
Bacterial Infections and Vaccines
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

USE OF CORTICOSTEROIDS AND ADJUVANTS IN THE TREATMENT OF BACTERIAL MENINGITIS — H. Silva, Elisabeth Dotti Consolo, et al. · Asclepius International Journal of Scientific Health Science (2025) | TGRS Research Map | TGRS